Secretory Leukocyte Protease Inhibitor in Cystic Fibrosis

Autor: Stromatt Sc

Publikováno v: Proteases, Protease Inhibitors and Protease-Derived Peptides ISBN: 9783034873994

Cystic fibrosis (CF) is a genetic disorder that leads to a defect in chloride ion transport and results in pancreatic and pulmonary insufficiency. The pulmonary disease is characterized by bacterial colonization and inflammation with excessive levels

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::90132ca642bf7529ab4d72449662dc51
https://doi.org/10.1007/978-3-0348-7397-0_9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.

Autor: Robak T; Department of Haematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland., Hellmann A; Department of Hematology, Medical University of Gdansk, Gdansk, Poland., Kloczko J; Department of Haematology, Medical University of Bialystok, Bialystok, Poland., Loscertales J; Haematology, Hospital Universitario La Princesa, IIS-IP Madrid, Spain., Lech-Maranda E; Department of Haematology, Institute of Haematology and Transfusion Medicine, Warsaw, Poland.; Department of Haematology and Transfusion Medicine, Centre of Postgraduate Medical Education, Warsaw, Poland., Pagel JM; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Mato A; Center for CLL, University of Pennsylvania and Hackensack University, Philadelphia, PA, USA., Byrd JC; Division of Hematology, The Ohio State University, Columbus, OH, USA., Awan FT; Division of Hematology, The Ohio State University, Columbus, OH, USA., Hebart H; Department of Haematology/Oncology, Stauferklinikum Schwaebisch Gmuend, Mutlangen, Germany., Garcia-Marco JA; Hospital U. Puerta de Hierro-Majadahonda, Madrid, Spain., Hill BT; Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Hallek M; Department I of Internal Medicine, Centre of Integrated Oncology Koln and Cluster of Excellence on Cellular Stress Responses in Aging (CECAD) University of Cologne, Cologne, Germany.; German CLL Study Group., Eisenfeld AJ; Aptevo Therapeutics, Seattle, WA, USA., Stromatt SC; Aptevo Therapeutics, Seattle, WA, USA., Jaeger U; German CLL Study Group.; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.

Publikováno v: British journal of haematology [Br J Haematol] 2017 Feb; Vol. 176 (4), pp. 618-628. Date of Electronic Publication: 2016 Dec 15.